Section Policy
Annals of Clinical and Analytical Medicine maintains specific policies for various article types, each tailored to ensure rigorous academic standards and valuable contributions to the field.
Original research articles should provide in-depth analysis, appropriate methodology, and valid results. All submitted research articles undergo double-blind peer review, evaluating their originality and scientific impact.
Review articles should offer a broad and updated perspective on relevant literature. They are published upon editorial approval and may be peer reviewed if necessary.
Case reports should highlight rare or instructive clinical findings. They are subject to double-blind peer review and must contribute new or notable insights.
Short communications summarize new findings or preliminary data. These concise articles are also evaluated through double-blind peer review.
Letters offer feedback or perspectives on published content. These are reviewed by the editor and may be peer-reviewed when appropriate.
All articles are published under open access and licensed under CC BY-NC 4.0. This permits free download, sharing, and referencing for non-commercial use with proper attribution.
All manuscripts undergo editorial screening followed by double-blind peer review. Evaluation focuses on originality, scientific contribution, methodology, and clarity.
Authors must comply with ethical publishing guidelines and disclose any conflicts of interest. Ethical approvals and data-sharing permissions are mandatory for all studies.
Authors may revise manuscripts based on reviewer feedback. Revised versions may be re-evaluated through peer review before final decision.
